North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...
A Novo Nordisk production facility in ... Novo also has a location in North Carolina where semaglutide is produced. That ...
announcing plans to build a $4.1 billion fill-and-finish facility for injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk’s ...
Bloomberg on MSN3mon
Novo’s Main Ozempic Plant Cited for Quality Lapses by FDA(Bloomberg) -- Novo Nordisk A/S was cited for quality ... Novo’s other site that makes semaglutide is in North Carolina. That ...
Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...
Novo Nordisk ... at Clayton in North Carolina, will focus on producing active pharmaceutical ingredients (APIs) for isemaglutide and other diabetes drugs, while the Danish plant in Måløv will ...
Novo Nordisk has been manufacturing some active pharmaceutical ingredients, and finished products, in the US, and is investing further, with a $4.1bn factory in North Carolina announced last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback